Background Red Shape Background Blue Shape Background Red Shape Background Blue Shape

Mission

Envisioning a world where we all age free from diseases of mind and sight.

BrightFocus Foundation is on a mission to cure Alzheimer’s disease and related dementias and stop vision loss in its tracks.

What We Do

We invest in the most promising science.

Our donors fuel the work of scientists who are paving the way toward cures for Alzheimer’s disease, macular degeneration, and glaucoma.
Happy family enjoying in public park

Over 50 Years of Bold Research

We believe that having the courage to invest in innovative ideas will lead to revolutionary therapies. Explore how the research we’ve funded has fostered life-changing breakthroughs across Alzheimer’s disease, macular degeneration, and glaucoma.

1 in 7

People over age 40 in the U.S. affected by Alzheimer’s disease, macular degeneration, or glaucoma.

202

Active scientific projects funded by BrightFocus worldwide.

6,386

Scientists from 25 countries supported by BrightFocus grants working toward cures.

Resources icon.

Resources

We’re here for you.

Find free resources, virtual information programs, and so much more to help you navigate Alzheimer’s disease, macular degeneration, and glaucoma.
A flat lay image of various colorful pills and tablets arranged neatly on a light blue background. The pills vary in shape, size, and color, including red, green, orange, pink, blue, white, and speckled designs.
Glaucoma Chats

Can Non-Drug Interventions Reduce Glaucoma Risk?

Can lifestyle changes help reduce glaucoma risk? Join us as glaucoma specialist Jullia A. Rosdahl, MD, PhD, discusses how diet, exercise, sleep, and other non-drug interventions may impact eye pressure and overall eye health. Learn about the latest research on nutrition, supplements, and daily habits that could support vision preservation.

Macular Chats Logo
Macular Chats

Light Therapy and Macular Degeneration: What You Need to Know

Join us for a conversation about light therapy and macular degeneration, where we’ll explore how different types of light—blue, red, and sunlight—affect the retina, the science behind light therapy, and the newly approved Valeda red light therapy

Rudolph E. Tanzi, PhD
Zoom In on Dementia & Alzheimer's

The Path Forward in Stopping Alzheimer’s Disease

Join our conversation with Dr. Rudolph Tanzi as he explains how stopping Alzheimer’s disease will require a combination of early detection using blood biomarkers, presymptomatic intervention with safe and affordable therapies, and lifestyle modifications.

Lawrence S. Geyman, MD, FAAO
Glaucoma Chats

Gathering Support For Your Glaucoma Diagnosis

Join Dr. Lawrence S. Geyman as he outlines effective ways to find support for your glaucoma diagnosis.

Jeffrey L. Cummings, MD, ScD.
Zoom In on Dementia & Alzheimer's

Navigating Clinical Trials for Alzheimer’s Disease

Join our conversation with Dr. Jeffrey L. Cummings, renowned expert in dementia drug development and research studies, for insights into the different types, qualification processes, and phases of studies that may be right for you or your loved one.

Expert Information

Environmental Pollution Can Increase Your Alzheimer’s Risk, Say BrightFocus-Funded Scientists

Urban and rural communities alike face potential long-term health consequences from environmental toxins that could lead to Alzheimer’s disease.

Pamela Ann Weber, MD
Macular Chats

Geographic Atrophy: Making An Informed Treatment Choice

Learn about how to navigate treatment options, engage in shared decision-making with your healthcare team, and maximize your eye health.

Charles C. Wykoff, MD, PhD, FASRS
Macular Chats

Wet AMD Treatments: Updates, Challenges, and Future Innovations

Join us for an in-depth discussion on the latest developments in wet age-related macular degeneration treatment.

Dilru Amarasekera, MD.
Glaucoma Chats

Glaucoma and Macular Degeneration: Can You Be Diagnosed With Both?

Learn about the similarities and differences between these two vision diseases, whether someone can develop both conditions at the same time, and how to reduce your risk.

Virtual Programs

Connect With Experts

Explore a variety of programs for people with Alzheimer’s, macular degeneration, and glaucoma to hear directly from experts, ask questions, and build community.

Zoom In on Dementia & Alzheimer’s

A live, interactive virtual discussion series with renowned research scientists and clinicians to keep you informed about the latest brain health breakthroughs and findings.

Watch Now

Macular Chats

Accessible audio conversations with scientists and vision experts about treatments, research breakthroughs, news, and tips for living with macular degeneration.

Listen Now

Glaucoma Chats

Scientists and vision experts weigh in about treatments, research breakthroughs, news, and tips for living with glaucoma through accessible audio conversations.

Listen Now
News loudspeaker icon.

News

Accelerating Progress in Brain and Vision Science

Read about the latest advancements to diagnose, slow the progression, treat, and ultimately cure these diseases of mind and sight.
Alzheimer's Disease Research wordmark.

Alzheimer’s Science News: Winter 2025

In this issue: Alzheimer’s Linked to Fragmented Sleep and Brain Degeneration, Researcher Spotlight: Brittany Butts, PhD, Alzheimer’s Disease: Home Safety Precautions, and more!

National Glaucoma Research wordmark.

National Glaucoma Research Report: Winter 2025

In this issue: Developing Tools to Prevent Vision Loss, Experimental Drug Could Improve Vision, Researcher Spotlight: Xiaorong Liu, PhD, and more!

Illustration of different human cells.

Could Listening in to Cellular Communication Help Treat Glaucoma?

By unlocking the secrets of how cells communicate, this first-of-its-kind BrightFocus National Glaucoma Research-funded study could help prevent vision loss and restore sight for those living with the disease.

A microscopic image of cultured retinal pigment epithelial cells.
A microscopic image of cultured retinal pigment epithelial cells. Photo Credit: NIH Flickr

Turning Back the Biological Clock on Aged and Injured Eye Cells

A de-aging technique offers hope for halting damage in early macular degeneration.

Happy senior couple sitting on the bench in park.

A BrightFocus-Funded Non-Invasive Treatment Slows Alzheimer’s Progression in Yearlong Study

Sinaptica Therapeutics unveils breakthrough Phase 2 results for an experimental non-invasive treatment for Alzheimer’s disease.

National Glaucoma Research wordmark.

National Glaucoma Research Report: Fall 2024

In This Issue: Blocking a “Master Switch” in the Eye to Treat Glaucoma, Growing Cells to Restore the Eye-Brain Connection, Researcher Spotlight: Mark Prausnitz, PhD, Treatment Options: Which One Is Right for You? And more!

A collage of colorful brain scans.

Breaking News Dispatch: A Non-Invasive Alzheimer’s Treatment, Early Detection, and More

Get the latest in Alzheimer’s screening and treatments.

Mature man squinting using laptop, looking at screen.

New Research Links Blue Light to Macular Degeneration Risk, Antioxidants May Offer Hope

Blue light ​may​ damage the eyes by causing unstable “free radicals” to form, ​which increases the risk of​ age-related macular degeneration. BrightFocus-funded research offers a potential way to protect the eyes from blue light.

Abstract artwork of a red brain surrounded by vibrant, intertwining blood vessels and neural pathways in red, blue, and pink.

Could Finding and Treating Tiny Blood Clots in the Brain Delay Alzheimer’s?

A BrightFocus-funded scientist is investigating a novel imaging tool that could be used to find treatable blood clots in the brain and slow the progression of Alzheimer’s disease.

Book icon for stories.

Perspectives

I appreciate BrightFocus Foundation’s support of funding high-risk, high-reward projects. That is what truly investing in the next generation of scientists means—supporting these new ideas, which can sometimes be high risk. But they also come with high rewards, and that is helping us to bring new ideas to the table.

Zahra Shirzadi, PhD, Alzheimer’s Disease Research Grant Recipient

Zahra smiling at the camera.
After I was diagnosed with age-related macular degeneration, I had no idea where to turn. Fortunately, a friend and neighbor shared with me a newsletter from BrightFocus Foundation. Since then, I have participated in the nonprofit’s monthly Macular Chats and Age-Related Macular Degeneration Community Circle group. I’ve been able to connect with people across the U.S. who are also living with macular degeneration. BrightFocus has been a huge part of my life.

Maureen Foley, Diagnosed with macular degeneration

Headshot of Maureen Foley
BrightFocus serves as a crucial catalyst for the careers of emerging investigators. By making their new findings possible, BrightFocus supports entire communities of scientists who have dedicated their lives to addressing these brain and eye conditions.

John S. Penn, PhD, Associate Dean and Professor of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine

Man with glasses and a gray beard, wearing a suit and red tie, smiling at the camera.
I am an artist, and shortly after I was diagnosed with age-related macular degeneration, I printed out a picture I painted to bring to my eye doctor. It was a picture of my granddaughter drinking a cup of hot cocoa. I wanted him to see what I do and how important my vision is to me.

Wynicia Clute, Diagnosed with macular degeneration

Woman wearing glasses with plants and flowers in the background.

Donate Now to Fund Critical Research

Your gift today can help drive innovation in Alzheimer’s, macular degeneration, and glaucoma research. By donating, you’ll support life-changing research and provide valuable resources for those affected by these devastating diseases. Give now to fuel hope and bring us closer to finding cures.

Get Involved

Ways to Support Our Work

There are many ways to get involved and help us defeat diseases of mind and sight.

Help Find a Cure

Nearly 1 in 10 U.S. adults aged 65 and older has dementia. Macular degeneration and glaucoma are leading causes of irreversible blindness, robbing millions of Americans of their vision and independence. Help us end these diseases for good.

Scientist working in lab.
Macular Degeneration Research grant recipient, Yong-Su Kwon, PhD

Search for a Clinical Trial

Clinical trials are key to advancing medical science, breakthroughs, treatments, and cures.

Their success depends on volunteer participants. Learn more about the clinical trial process and find a clinical trial near you.

Group of five people standing in front of a branded backdrop, smiling at the camera.

Become a Partner

We work with public and private companies that share our values and commitment to end these diseases.